Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.435 USD | +8.75% | +0.05% | +40.78% |
May. 15 | Brookline Capital Upgrades Dare Bioscience to Buy From Hold, Price Target is $3 | MT |
May. 14 | Transcript : Daré Bioscience, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.78% | 40.23M | |
+64.28% | 62.59B | |
-1.08% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.41% | 26.21B | |
-21.53% | 19.09B | |
+4.91% | 13.08B | |
+25.72% | 12.26B | |
+28.81% | 12.05B |
- Stock Market
- Equities
- DARE Stock
- News Daré Bioscience, Inc.
- Transcript : Daré Bioscience, Inc., Q1 2021 Earnings Call, May 13, 2021